Annual Drug Patent Expirations for LONSURF
Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has seventy-six patent family members in thirty-one countries.
The generic ingredient in LONSURF is tipiracil hydrochloride; trifluridine. One supplier is listed for this compound. Additional details are available on the tipiracil hydrochloride; trifluridine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
